RecruitingNCT01106794
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
Sponsor
Children's National Research Institute
Enrollment
100 participants
Start Date
Apr 1, 2010
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to prospectively collect specimens from pediatric patients with diffuse intrinsic pontine glioma or brainstem glioma, either during therapy or at autopsy, in order to characterize the molecular abnormalities of this tumor.
Eligibility
Max Age: 21 Years
Plain Language Summary
Simplified for easier understanding
This study collects and analyzes tumor samples from patients with brainstem gliomas (brain tumors located in the brainstem) to understand the molecular makeup of these cancers and find better treatment targets.
**You may be eligible if...**
- You have been diagnosed with diffuse intrinsic pontine glioma (DIPG), a type of brainstem tumor, at any age
- You have another type of high-grade (aggressive) glioma originating in the brainstem
- You have a low-grade (slower-growing) focal glioma of the brainstem
**You may NOT be eligible if...**
- Your brain tumor started outside the brainstem (even if it spread there)
- You have a brainstem tumor of a different cell type (e.g., primitive neuroectodermal tumor)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01106794
Related Trials
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
NCT040997971 location
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
NCT0584325321 locations
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
NCT041850381 location
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
NCT0646519910 locations
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
NCT0509648112 locations